These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16481044)

  • 41. Equine interferons following exposure to equid herpesvirus-1 or -4.
    Edington N; Bridges CG; Griffiths L
    J Interferon Res; 1989 Aug; 9(4):389-92. PubMed ID: 2474039
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination.
    Minke JM; Fischer L; Baudu P; Guigal PM; Sindle T; Mumford JA; Audonnet JC
    Vet Immunol Immunopathol; 2006 May; 111(1-2):47-57. PubMed ID: 16580075
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antibody to neuritogenic myelin protein P2 in equine paresis due to equine herpesvirus 1.
    Klingeborn B; Dinter Z; Hughes RA
    Zentralbl Veterinarmed B; 1983 Mar; 30(2):137-40. PubMed ID: 6190332
    [No Abstract]   [Full Text] [Related]  

  • 44. [Vaccination against Rhinopneumonia].
    Binkhorst GJ
    Tijdschr Diergeneeskd; 1994 Jan; 119(1):20. PubMed ID: 8291048
    [No Abstract]   [Full Text] [Related]  

  • 45. Evaluation of metaphylactic RNA interference to prevent equine herpesvirus type 1 infection in experimental herpesvirus myeloencephalopathy in horses.
    Perkins GA; Van de Walle GR; Pusterla N; Erb HN; Osterrieder N
    Am J Vet Res; 2013 Feb; 74(2):248-56. PubMed ID: 23363350
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Updated ACVIM consensus statement on equine herpesvirus-1.
    Lunn DP; Burgess BA; Dorman DC; Goehring LS; Gross P; Osterrieder K; Pusterla N; Soboll Hussey G
    J Vet Intern Med; 2024; 38(3):1290-1299. PubMed ID: 38497217
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Disseminated equine herpesvirus-1 infection in a two-year-old filly.
    Hamir AN; Vaala W; Heyer G; Moser G
    J Vet Diagn Invest; 1994 Oct; 6(4):493-6. PubMed ID: 7858033
    [No Abstract]   [Full Text] [Related]  

  • 48. Detection of equine herpesvirus-specific effector and memory cytotoxic immunity in the equine upper respiratory tract.
    Breathnach CC; Yeargan MR; Timoney JF; Allen GP
    Vet Immunol Immunopathol; 2006 May; 111(1-2):117-25. PubMed ID: 16472871
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevention of equine herpesvirus myeloencephalopathy - Is heparin a novel option? A case report.
    Walter J; Seeh C; Fey K; Bleul U; Osterrieder N
    Tierarztl Prax Ausg G Grosstiere Nutztiere; 2016 Oct; 44(5):313-317. PubMed ID: 27652372
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antibody and cellular immune responses following DNA vaccination and EHV-1 infection of ponies.
    Soboll G; Hussey SB; Whalley JM; Allen GP; Koen MT; Santucci N; Fraser DG; Macklin MD; Swain WF; Lunn DP
    Vet Immunol Immunopathol; 2006 May; 111(1-2):81-95. PubMed ID: 16549215
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Equine rhinopneumonitis vaccine: immunogenicity and safety in foals.
    Purdy CW; Porter RC; Ford SJ
    Am J Vet Res; 1978 May; 39(5):745-52. PubMed ID: 215062
    [No Abstract]   [Full Text] [Related]  

  • 52. Equine herpesviruses 4 (equine rhinopneumonitis virus) and 1 (equine abortion virus).
    Crabb BS; Studdert MJ
    Adv Virus Res; 1995; 45():153-90. PubMed ID: 7793324
    [No Abstract]   [Full Text] [Related]  

  • 53. Nasal shedding of equine herpesvirus-1 from horses in an outbreak of equine herpes myeloencephalopathy in Western Canada.
    Burgess BA; Tokateloff N; Manning S; Lohmann K; Lunn DP; Hussey SB; Morley PS
    J Vet Intern Med; 2012; 26(2):384-92. PubMed ID: 22332764
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Skin hypersensitivity to equid herpesvirus type 1 in horses.
    Frymus T; Woyciechowska S; Schollenberger A; Poliwoda A
    Zentralbl Veterinarmed B; 1978 Jun; 25(5):431-4. PubMed ID: 211756
    [No Abstract]   [Full Text] [Related]  

  • 55. In vitro stimulation of foal lymphocytes with equid herpesvirus 1.
    Thomson GR; Mumford JA
    Res Vet Sci; 1977 May; 22(3):347-52. PubMed ID: 195321
    [No Abstract]   [Full Text] [Related]  

  • 56. Pathogenesis of equine herpesvirus-associated neurological disease: a revised explanation.
    Borchers K; Thein R; Sterner-Kock A
    Equine Vet J; 2006 May; 38(3):283-7. PubMed ID: 16706288
    [No Abstract]   [Full Text] [Related]  

  • 57. A review of equid herpesvirus 1 for the veterinary practitioner. Part B: pathogenesis and epidemiology.
    Dunowska M
    N Z Vet J; 2014 Jul; 62(4):179-88. PubMed ID: 24597839
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence of equine herpesvirus-1 and equine herpesvirus-4 infections in equidae species in Turkey as determined by ELISA and multiplex nested PCR.
    Ataseven VS; Dağalp SB; Güzel M; Başaran Z; Tan MT; Geraghty B
    Res Vet Sci; 2009 Apr; 86(2):339-44. PubMed ID: 18649902
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Herpesviral diseases affecting reproduction in the horse.
    Bryans JT
    Vet Clin North Am Large Anim Pract; 1980 Nov; 2(2):303-12. PubMed ID: 6262988
    [No Abstract]   [Full Text] [Related]  

  • 60. [Neurologic form of rhinopneumonia].
    Sloet van Oldruitenborgh-Oosterbaan M
    Tijdschr Diergeneeskd; 2005 Oct; 130(20):629-31. PubMed ID: 16276730
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.